Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

Toonaangevende leiders

Alle informatieOndernemingenMarktenEconomie & ForexgrondstoffenRenteToonaangevende leidersFinanciŽle professionalAgendaSectoren 
HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŽn van de Leiders
Portrait de Barbara J. Dalton
Leeftijd : 65
Belangrijkste bedrijven : Pfizer Inc. - IMARA Inc.
Overzicht 
Barbara J. Dalton is Vice President at Pfizer Venture Investments, Vice President-Worldwide Business Development at Pfizer Inc., Director at Ijetset Corp. and Director at Terragen Discovery, Inc. and on the board of 13 other companies.

In her past career Dr. Dalton held the position of Director at National Venture Capital Association, General Partner at EuclidSR Partners, Independent Director at Celladon Corp., Chairman for Scimagix, Inc., President for GSK Equity Investments Ltd and Director at Physiome Sciences, Inc.

Dr. Dalton received a doctorate from Drexel University College of Medicine and an undergraduate degree from Eberly College of Science.


Posities en verantwoordelijkheden van Barbara J. Dalton 
NaamTitel Van
IMARA Inc.
(Biotechnologie & Medisch Onderzoek)
Independent Director 2016
Pfizer Inc.
(Farmaceutische producten)
Vice President-Worldwide Business Development 2007
Pfizer Venture Investments Vice President 2012
Complexa, Inc. Director -
Ablexis LLC Director -
Second Genome, Inc. Director -
Cydan II, Inc. Director -
Cydan LLC Director -
Ixchelsis Ltd. Director -
Penn State Research Foundation Director -
Vtesse, Inc. Director -
Advanced MR Analytics AB Director -
Petra Pharma Corp. Director -
Artios Pharma Ltd. Director -
AMRA Medical AB Director -
Terragen Discovery, Inc. Director -


Belangnemingen van Barbara J. Dalton 
NaamAandelen%Totale waarde
IMARA Inc. (IMRA)
(Biotechnologie & Medisch Onderzoek)
00,0000%0 USD


Barbara J. DaltonPersoonlijk netwerk 
Meest gelezen nieuws 
15/09BRAD SMITH : Microsoft kondigt inkoop van eigen aandelen aan tot $60 mrd, verhoogt dividend
MR
13/09MARTIN SORRELL : Sorrell's S4 Capital verhoogt winstverwachting tot 40%
MR
14/09STEPHEN SCHERR : Goldman Sachs benoemt Coleman als nieuwe CFO, ter vervanging van Scherr
MR
15/09ILHAM KADRI : Activist Bluebell Capital wil ontslag CEO Solvay
AM
Meer nieuws


© 2021 People and Ownership :   
Barbara J. Dalton Verbindingen